Rankings

Market Cap
Revenue
Operating Income
CapEx
Total Assets
Net Assets
Cash on Hand

Sectors

Technology
Healthcare
Financial Services
Consumer Cyclical
Communication Services
Industrials
Consumer Defensive
Energy
Basic Materials
Real Estate
Utilities

Pages

Home
Earnings Calendar
All Sectors
Terms
Privacy

© 2026 Market Cap Arena. All rights reserved.v1.2.29

ZBIO FY 2022 Earnings — Zenas BioPharma, Inc. Revenue & Financial Results | Market Cap Arena

ZBIOZenas BioPharma, Inc.

$1B

FY 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$62M

Operating Income

-$76M

Net Income

-$119M

EPS (Diluted)

$-3.11

Cash Flow

Operating Cash Flow

-$66M

Free Cash Flow

-$68M

Stock-Based Comp.

$737,000

Balance Sheet

Total Assets

$75M

Total Liabilities

$267M

Stockholders' Equity

-$192M

Cash & Equivalents

$67M

← Q4 2022 All Quarters